Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:DPLO

Diplomat Pharmacy (DPLO) Stock Price, News & Analysis

Diplomat Pharmacy logo

About Diplomat Pharmacy Stock (NYSE:DPLO)

Advanced Chart

Key Stats

Today's Range
$4.00
$4.01
50-Day Range
$4.00
$4.00
52-Week Range
$2.43
$14.46
Volume
744,968 shs
Average Volume
545,194 shs
Market Capitalization
$304 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DPLO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diplomat Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

DPLO Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

DPLO Stock Analysis - Frequently Asked Questions

Diplomat Pharmacy Inc (NYSE:DPLO) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($2.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $2.15. The business's revenue was down 5.3% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diplomat Pharmacy investors own include Bausch Health Cos (BHC), Gilead Sciences (GILD), Bristol Myers Squibb (BMY), Cara Therapeutics (CARA), Cannabis Sativa (CBDS), CVS Health (CVS) and Jazz Pharmaceuticals (JAZZ).

Company Calendar

Last Earnings
11/12/2019
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drug Stores & Proprietary Stores
Sub-Industry
N/A
Current Symbol
NYSE:DPLO
Fax
N/A
Employees
2,335
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$302.27 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.49 billion
Cash Flow
$4.60 per share
Price / Cash Flow
0.87
Book Value
$6.24 per share
Price / Book
0.64

Miscellaneous

Free Float
N/A
Market Cap
$304 million
Optionable
Optionable
Beta
0.82
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSE:DPLO) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners